IQVIQVIA Holdings Inc.

$30B

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$16.3B+5.9% YoY

Gross Profit

$4.3B26.3% margin

Operating Income

$2.3B14.0% margin

Net Income

$1.4B8.3% margin

EPS (Diluted)

$7.84

Cash Flow

Operating Cash Flow

$2.7B

Free Cash Flow

$2.1B

Stock-Based Comp.

$247M

Balance Sheet

Total Assets

$29.9B

Total Liabilities

$23.3B

Stockholders' Equity

$6.5B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.3B	$15.4B	+5.9%
Gross Profit	$4.3B	$5.4B	-20.3%
Operating Income	$2.3B	$2.2B	+3.9%
Net Income	$1.4B	$1.4B	-0.9%

IQV FY 2025 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena